THE LATEST
Children’s Cancer is Unprofitable and Ignored – An SKC Featured Article
John London, co-founder of SKC, wanted to scream in frustration. After three years of treatment, doctors suggested that him and his wife took his daughter, Penelope, home to enjoy their remaining time together. Instead, John scanned hundreds of research abstracts seeking new treatments.
Understanding the Landscape, Strengthening the Science, Curing and Caring for the Child
Solving Kids’ Cancer’s approach is to understand the research landscape, strengthen the science, cure, and care for the child. The GD2 T Cell Therapy trial at Texas Children’s Hospital is helping children with neuroblastoma like Kyra Kardong – listen to her story.
The Promise of Immunotherapy
Immunotherapy is changing the paradigm for children with cancer. Solving Kids’ Cancer has teamed up with the same researchers who helped save Emily Whitehead’s life to bring a new treatment option for children with neuroblastoma. Meet one family that was on a Solving Kids’ Cancer clinical trial at the Children’s Hospital of Philadelphia
Solving Kids’ Cancer Nifurtimox trial: Meet one Family
Jordyn being diagnosed at 6 months old with neuroblastoma was a devastating shock for her mother, Jodie. After 6 ineffective rounds of chemotherapy, radiation, and surgery Jodie was left without any options, which in turn lead her to an experimental clinical trial sponsored by Solving Kids’ Cancer. This is the story of their journey to save Jordyn.
Searching for a Solution: An SKC Feature
Al Jazeera America covered the story of Solving Kids’ Cancer’s co-founders, Scott Kennedy & John London, and why they created the organization. Listen in on their stories and the inspiration behind the making of Solving Kids’ Cancer.
Challenging the Status Quo
“Solving Kids’ Cancer and the TDI offer the opportunity to develop a much more facile system for drug development.” – Dr. Kenneth Cohen from the Sidney Kimmel Cancer Center at John Hopkins University